3-Methoxy-a-methylbenzeneethanamine

Category

3-Methoxy-a-methylbenzeneethanamine




Useful info

3-Methoxy-a-methylbenzeneethanamine Brand names, 3-Methoxy-a-methylbenzeneethanamine Analogs

3-Methoxy-a-methylbenzeneethanamine Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

    • 3-Methoxy-a-methylbenzeneethanamine Chemical_Formula

    C9H13N

    3-Methoxy-a-methylbenzeneethanamine RX_link

    http://www.rxlist.com/cgi/generic3/adderallxr.htm

    3-Methoxy-a-methylbenzeneethanamine fda sheet

    3-Methoxy-a-methylbenzeneethanamine msds (material safety sheet)

    3-Methoxy-a-methylbenzeneethanamine Synthesis Reference

    U. S. Pat. 1,879,003, (1932)

    3-Methoxy-a-methylbenzeneethanamine Molecular Weight

    135.206 g/mol

    3-Methoxy-a-methylbenzeneethanamine Melting Point

    Volatizes slowly at room temperature

    3-Methoxy-a-methylbenzeneethanamine H2O Solubility

    Slightly

    3-Methoxy-a-methylbenzeneethanamine State

    Solid

    3-Methoxy-a-methylbenzeneethanamine LogP

    1.799

    3-Methoxy-a-methylbenzeneethanamine Dosage Forms

    Capsules

    3-Methoxy-a-methylbenzeneethanamine Indication

    For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

    3-Methoxy-a-methylbenzeneethanamine Pharmacology

    Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

    3-Methoxy-a-methylbenzeneethanamine Absorption

    It forms easily absorbed molecules that are highly lipid soluble

    3-Methoxy-a-methylbenzeneethanamine Toxicity

    LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

    3-Methoxy-a-methylbenzeneethanamine Patient Information

    Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

    3-Methoxy-a-methylbenzeneethanamine Organisms Affected

    Humans and other mammals